基本信息
浏览量:3
职业迁徙
个人简介
He did his PhD at the Hospital Clinic of Barcelona focusing his research on the characterisation of immune responses following clinical liver transplantation and identification of tolerance biomarkers. He was awarded the Doctorate Extraordinary Reward in 2009 by the School of Medicine at the University of Barcelona.
In 2010, he joined the Diabetes Center at the University of California San Francisco, where he studied the role of regulatory T cells and co-stimulatory signals in the antigen-specific responses.
The research in his laboratory has focused on the monitoring of immune responses in clinical trials and the investigation of the mechanisms modulating the homeostasis and function of regulatory T cells. In the last few years, his research has implemented the combination of translational research employing animals models with the phenotypic analysis of patient samples to design and develop new therapies to regulate immune responses, particularly on liver transplantation and other hepatic inflammatory diseases. He is currently collaborating in different clinical trials in liver transplantation to develop tolerance predictor biomarkers (LIFT) and Treg-directed therapies to promote allograft acceptance (ThRIL and LITE).
In 2010, he joined the Diabetes Center at the University of California San Francisco, where he studied the role of regulatory T cells and co-stimulatory signals in the antigen-specific responses.
The research in his laboratory has focused on the monitoring of immune responses in clinical trials and the investigation of the mechanisms modulating the homeostasis and function of regulatory T cells. In the last few years, his research has implemented the combination of translational research employing animals models with the phenotypic analysis of patient samples to design and develop new therapies to regulate immune responses, particularly on liver transplantation and other hepatic inflammatory diseases. He is currently collaborating in different clinical trials in liver transplantation to develop tolerance predictor biomarkers (LIFT) and Treg-directed therapies to promote allograft acceptance (ThRIL and LITE).
研究兴趣
论文共 66 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Trishan Vaikunthanathan, Emmanuelle Landmann, Diana Marin Correa,Marco Romano,Silvia Cellone Trevelin,Qi Peng,Elena Crespo,Mauro Corrado,Juan-Jose Lozano,Erika L. Pearce, Elena Perpinan,Anna Zoccarato,
EBioMedicine (2023): 104778-104778
Hepatology research : the official journal of the Japan Society of Hepatologyno. 8 (2023): 771-785
Tiong Yeng Lim,Elena Perpinan,Maria Carlota Londono,Rosa Miquel,Paula Ruiz,Ada Kurt, Elisavet Codela,Amy Cross,Claudia Berlin,Joanna Hester,Fadi Issa,Abdel Douiri,
Tiong Y Lim,Elena Perpiñán, Maria-Carlota Londoño,Rosa Miquel,Paula Ruiz, Ada S Kurt,Elisavet Kodela,Amy R Cross,Claudia Berlin, Joanna Hester,Fadi Issa,Abdel Douiri,
Ada S. Kurt,Karoline Strobl,Paula Ruiz,Gabriel Osborn,Tonika Chester, Lauren Dawson, Karsten M. Warwas, Elizabeth H. Grey,Sotiris Mastoridis,Elisavet Kodela,Niloufar Safinia,Alberto Sanchez-Fueyo,
Alberto Sánchez-Fueyo,Gavin Whitehouse,Nathali Grageda,Matthew E Cramp,Tiong Y Lim,Marco Romano, Sarah Thirkell,Katie Lowe,Laura Fry, Julie Heward,Alex Kerr, Jakia Ali,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn